Table 4.
Prognostic factors of long survival in univariate and multivariate analyses.
| n = 120 | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| HR | 95% CI | HR | 95% CI | |
| Age | ||||
| <65 | 1 | |||
| ≥65 | 1.60 | (0.95; 2.70) | ||
| p = 0.085 | ||||
| WHO Performance status | ||||
| 0 | 1 | |||
| 1–2 | 1.15 | (0.42; 3.18) | ||
| p = 0.790 | ||||
| FIGO stage | ||||
| III | 1 | |||
| IV | 1.08 | (0.53; 2.19) | ||
| p = 0.830 | ||||
| N stage | ||||
| N− | 1 | |||
| N+ | 1.33 | (0.75; 2.38) | ||
| p = 0.325 | ||||
| BRCA mutation | ||||
| Mutated BRCA1/2 | 1 | |||
| No mutation | 1.02 | (0.43; 2.44) | ||
| p = 0.958 | ||||
| Primary or interval surgery | ||||
| Complete | 1 | |||
| Incomplete | 1.92 | (1.17; 3.14) | ||
| p = 0.011 | ||||
| Initial PCI | ||||
| <17 | 1 | |||
| ≥17 | 1.78 | (0.96; 3.27) | ||
| p = 0.079 | ||||
| Sensibility to 1st CT line | ||||
| Refractory/Resistant | 1 | |||
| Sensitive | 0.47 | (0.19; 1.19) | ||
| p = 0.149 | ||||
| Progression-free interval | ||||
| <18 months | 1 | 1 | ||
| ≥18 months | 0.23 | (0.13; 0.40) | 0.23 | [0.13; 0.40] |
| p < 0.0001 | p < 0.0001 | |||
HR: hazard ratio, 95% CI: 95% confidence interval, WHO: World Health Organization, FIGO: Fédération Internationale de Gynécologie et d’Obstétrique, BRCA1: breast cancer 1, PCI: peritoneal carcinomatosis index, and CT: chemotherapy.